Literature DB >> 30452919

Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases.

Brona Wynne1, Louise McHugh1, Wei Gao2, Denise Keegan3, Kathryn Byrne3, Catherine Rowan3, Karen Hartery3, Clemens Kirschbaum2, Glen Doherty3, Garret Cullen3, Barbara Dooley1, Hugh E Mulcahy4.   

Abstract

BACKGROUND & AIMS: Patients with Crohn's disease or ulcerative colitis have relatively high levels of stress and psychological dysfunction. Acceptance and commitment therapy (ACT) is a psychological intervention that comprises acceptance and mindfulness procedures, along with commitment and behavior change strategies, to increase psychological flexibility and reduce stress. We performed a randomized controlled trial to investigate the effect of ACT on stress in patients with inflammatory bowel diseases (IBD).
METHODS: A total of 122 patients with quiescent or stable, mildly active IBD were randomly assigned to an 8-week ACT program or treatment as usual (control group). Clinical, demographic, disease activity, and psychological data and blood and feces were collected at baseline and at 8 weeks and 3 months after the intervention (week 20). Scalp hair was collected at baseline and week 20 for measurement of steroid concentrations. The primary endpoint was change in stress symptoms, assessed with the Depression Anxiety Stress Scale. Secondary endpoints included changes in perceived stress, anxiety, depression, quality-of-life domains, disease activity, and cortisol concentration in hair.
RESULTS: Overall, 79 participants were included in the complete case intention-to-treat analysis. There were 39% and 45% reductions in stress in the treatment group from baseline to 8 and 20 weeks, respectively, compared with 8% and 11% in the control group (group × time interaction, P = .001). ACT was associated with reduced perceived stress (P = .036) and depression (P = .010), but not anxiety (P = .388), compared with control individuals. In the intention-to-treat analysis, changes in all 4 quality-of-life domains over time were similar in the ACT and control groups. In the per-protocol analysis, the overall well-being quality-of-life domain improved in the ACT group compared with the control group (P = .009). Subjective and objective disease activity measurements were similar between groups over the study period (all P values >.05). Hair cortisol concentrations correlated with stress (rs = 0.205, P = .050) and anxiety (rs = 0.208, P = .046) at baseline but did not change significantly in the ACT group over the study period compared with the control group (P = .831).
CONCLUSION: In a randomized controlled trial of patients with IBD, an 8-week ACT therapy course improved stress and other indices of psychological health.ClinicalTrials.gov Identifier: NCT02350920.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acceptance and Commitment Therapy; Hair Cortisol Concentration; Inflammatory bowel disease; Psychological Stress

Mesh:

Substances:

Year:  2018        PMID: 30452919     DOI: 10.1053/j.gastro.2018.11.030

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  33 in total

1.  Effects of Psychotherapy on Hope/Hopelessness in Adults with Cancer: a Systematic Review and Meta-analysis.

Authors:  Jing Luo; Lixiang Li; Chuntana Reangsing; Joanne Kraenzle Schneider
Journal:  Int J Behav Med       Date:  2022-02-08

Review 2.  Implementing psychological therapies for gastrointestinal disorders in pediatrics.

Authors:  Bonney Reed; Jessica Buzenski; Miranda A L van Tilburg
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2020-08-18       Impact factor: 3.869

3.  Guidelines for the management of patients with Crohn's disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.

Authors:  Michał Łodyga; Piotr Eder; Magdalena Gawron-Kiszka; Agnieszka Dobrowolska; Maciej Gonciarz; Marek Hartleb; Maria Kłopocka; Ewa Małecka-Wojciesko; Piotr Radwan; Jarosław Reguła; Edyta Zagórowicz; Grażyna Rydzewska
Journal:  Prz Gastroenterol       Date:  2021-11-19

4.  The Effect of Acceptance and Commitment Therapy on Psychological Nursing of Acute Cerebral Infarction with Insomnia, Anxiety, and Depression.

Authors:  Xinyu Wang; Jie Chen; Yun-E Liu; Yan Wu
Journal:  Comput Math Methods Med       Date:  2022-06-22       Impact factor: 2.809

Review 5.  Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist.

Authors:  Emily Weaver; Eva Szigethy
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

6.  Preliminary investigation of the associations between psychological flexibility, symptoms and daily functioning in people with chronic abdominal pain.

Authors:  Lin Yu; Yoram Inspector; Lance M McCracken
Journal:  Br J Pain       Date:  2020-06-03

7.  Extending the Common Sense Model to Explore the Impact of Visceral Sensitivity on Quality of Life in Inflammatory Bowel Disease.

Authors:  Bree Hayes; Rebecca Burgell; Pragalathan Apputhurai; Mayur Garg; Simon R Knowles
Journal:  Turk J Gastroenterol       Date:  2022-02       Impact factor: 1.555

8.  Toward Further Understanding of Crohn's Disease-Related Fatigue: The Role of Depression and Emotional Processing.

Authors:  Ingrid Banovic; Louise Montreuil; Marie Derrey-Bunel; Fabrizio Scrima; Guillaume Savoye; Laurent Beaugerie; Marie-Claire Gay
Journal:  Front Psychol       Date:  2020-04-30

Review 9.  Measures of Psychosocial Stress and Stressful Exposures.

Authors:  Sarah L Patterson; Sara Sagui-Henson; Aric A Prather
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-10       Impact factor: 4.794

10.  Online Acceptance and Commitment Therapy and Nutrition Workshop for Parents of Children with Inflammatory Bowel Disease: Feasibility, Acceptability, and Initial Effectiveness.

Authors:  Sara Ahola Kohut; Inez Martincevic; Sheri L Turrell; Peter C Church; Thomas D Walters; Natalie Weiser; Armanda Iuliano
Journal:  Children (Basel)       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.